AstraZeneca shares data from HIMALAYA, MATTERHORN Phase III studies at ESMO Asia Congress 2023 Read more
Sentynl completes asset transfer of CUTX-101 Copper Histidinate product candidate for treatment of Menkes Disease from Cyprium Read more
Industry and academia should work together to combine discovery biology and translational research Read more
Non-stimulants face uphill battle to penetrate ADHD market despite lower abuse potential: GlobalData Read more